ENHANCEMENT OF ALLOGRAFT SURVIVAL BY COMBINATION RS-61443 AND DUP-785 THERAPY
PROLONGATION OF CANINE INTESTINAL ALLOGRAFT SURVIVAL WITH RS-61443, CYCLOSPORINE, AND PREDNISONE
HAMSTER-TO-RAT HEART AND LIVER XENOTRANSPLANTATION WITH FK506 PLUS ANTIPROLIFERATIVE DRUGS
PROLONGING DISCORDANT XENOGRAFT SURVIVAL WITH ANTICOMPLEMENT REAGENTS K76COOH AND FUT175
TREATMENT OF SEVERE DIABETES MELLITUS FOR MORE THAN ONE YEAR USING A VASCULARIZED HYBRID ARTIFICIAL PANCREAS
ISLET ALLOGRAFT, ISLET XENOGRAFT, AND SKIN ALLOGRAFT SURVIVAL IN CD8
NONHUMAN PRIMATE RESPONSES TO MURINE AND HUMANIZED OKT4A
LIVERS FROM FASTED RATS ACQUIRE RESISTANCE TO WARM AND COLD ISCHEMIA INJURY
ASSESSMENT OF PURINE METABOLISM IN HUMAN RENAL TRANSPLANTATION
A RAT FATTY LIVER TRANSPLANT MODEL
THE EFFECT OF IMMUNOSUPPRESSION ON PRE-EXISTING CANCERS
A RANDOMIZED, PROSPECTIVE, DOUBLE-BLINDED TRIAL OF CYCLOSPORINE VS. OG37–325 IN CADAVERIC RENAL TRANSPLANTATION—A PRELIMINARY REPORT
LRISK FACTORS FOR CHRONIC REJECTION IN RENAL ALLOGRAFT RECIPIENTS
HALF-LIFE AND RISK FACTORS FOR KIDNEY TRANSPLANT OUTCOME—IMPORTANCE OF DEATH WITH FUNCTION
FREQUENCY OF KIDNEY REJECTION IN DIABETIC PATIENTS UNDERGOING SIMULTANEOUS KIDNEY AND PANCREATIC ISLET CELL TRANSPLANTATION
A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTS
TUMOR NECROSIS FACTOR ALPHA IN HUMAN KIDNEY TRANSPLANT REJECTION—ANALYSIS BY IN SITU HYBRIDIZATION
DNA HLA-DR TYPING RESULTS OF 4000 KIDNEY TRANSPLANTS
RENAL TRANSPLANTATION FOLLOWING IMMUNOADSORPTION IN HIGHLY SENSITIZED RECIPIENTS
STEROID WITHDRAWAL FROM LONG-TERM IMMUNOSUPPRESSION IN LIVER ALLOGRAFT RECIPIENTS
HEPATITIS C VIRUS INFECTION IN PEDIATRIC LIVER TRANSPLANTATION
COMPLEMENT ACTIVATION DURING LIVER TRANSPLANTATION
HEPATIC RETRANSPLANTATION IN NEW ENGLAND—A REGIONAL EXPERIENCE AND SURVIVAL MODEL
RISK FACTORS FOR PRIMARY DYSFUNCTION AFTER LIVER TRANSPLANTATION—A MULTIVARIATE ANALYSIS
PROBABLE ANTIBODY-MEDIATED FAILURE OF TWO SEQUENTIAL ABO-COMPATIBLE HEPATIC ALLOGRAFTS IN A SINGLE RECIPIENT
EVIDENCE THAT INTRAOPERATIVE PROSTAGLANDIN E1 INFUSION REDUCES IMPAIRED PLATELET AGGREGATION AFTER REPERFUSION IN ORTHOTOPIC LIVER TRANSPLANATION
RIGHT PHRENIC NERVE INJURY IN ORTHOTOPIC LIVER TRANSPLANTATION
HEPATIC LIDOCAINE METABOLISM AND COMPLICATIONS OF CIRRHOSIS IMPLICATIONS FOR ASSESSING PATIENT PRIORITY FOR HEPATIC TRANSPLANTATION
IMPROVED RESULTS OF LIVING-RELATED LIVER TRANSPLANTATION WITH ROUTINE APPLICATION IN A PEDIATRIC PROGRAM
REDUCTION BY COMBINATION PROPHYLACTIC THERAPY WITH CMV HYPERIMMUNE GLOBULIN AND ACYCLOVIR OF THE RISK OF PRIMARY CMV DISEASE IN RENAL TRANSPLANT RECIPIENTS
PREDICTION OF RECURRENT CYTOMEGALOVIRUS DISEASE AFTER TREATMENT WITH GANCICLOVIR IN SOLID-ORGAN TRANSPLANT RECIPIENTS
CYTOMEGALOVIRUS INFECTION—AN ETIOLOGICAL FACTOR FOR REJECTION? A PROSPECTIVE STUDY IN 242 RENAL TRANSPLANT PATIENTS
PROLONGATION OF CARDIAC XENOGRAFT SURVIVAL BY DEPLETION OF COMPLEMENT
PROLONGED SURVIVAL OF RAT ORTHOTOPIC LIVER ALLOGRAFTS AFTER INTRATHYMIC INOCULATION OF DONOR-STRAIN CELLS
DELETION OF DONOR-REACTIVE T LYMPHOCYTES IN ADULT MICE AFTER INTRATHYMIC INOCULATION WITH LYMPHOID CELLS
INDUCTION OF DONOR-SPECIFIC TOLERANCE TO CARDIAC BUT NOT SKIN OR RENAL ALLOGRAFTS BY INTRATHYMIC INJECTION OF SPLENOCYTE ALLOANTIGEN
DO DONOR CELLS FUNCTION AS VETO CELLS IN THE INDUCTION AND MAINTENANCE OF TOLERANCE ACROSS AN MHC DISPARITY IN MIXED LYMPHOID RADIATION CHIMERAS?
THE MECHANISM OF UNRESPONSIVENESS TO ALLOGRAFTS INDUCED BY RAPAMYCIN AND RAPAMYCIN/CYCLOSPORINE TREATMENT IN RATS
THE SYNERGISTIC INTERACTIONS IN VITRO AND IN VIVO OF BREQUINAR SODIUM WITH CYCLOSPORINE OR RAPAMYCIN ALONE AND IN TRIPLE COMBINATION
ANTI-CD2 AND ANTI-CD3 MONOCLONAL ANTIBODIES SYNERGIZE TO PROLONG ALLOGRAFT SURVIVAL WITH DECREASED SIDE EFFECTS
EVIDENCE FOR A NONCLASSICAL PATHWAY OF GRAFT REJECTION INVOLVING INTERLEUKIN 5 AND EOSINOPHILS
ALLOANTIGEN-DEPENDENT ENDOTHELIAL PHENOTYPE AND LYMPHOKINE mRNA EXPRESSION IN REJECTING MURINE CARDIAC ALLOGRAFTS
THE HUMAN ANTIPORCINE CELLULAR REPERTOIRE
DELIVERY OF WHOLE LIVER-EQUIVALENT HEPATOCYTE MASS USING POLYMER DEVICES AND HEPATOTROPHIC STIMULATION
PREVENTION OF INSULITIS AND DIABETES IN NONOBESE DIABETIC MICE BY ADMINISTRATION OF FK506
USE OF DONOR β2-MICROGLOBULIN-DEFICIENT TRANSGENIC MOUSE LIVER CELLS FOR ISOGRAFTS, ALLOGRAFTS, AND XENOGRAFTS
BRIEF COMMUNICATION
LETTERS TO EDITOR